Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
PL03 - Plenary 3: Presidential Symposium - Top Rated Abstracts (Live Streamed Session)
- 08:30 - 10:20
- 8/08/2022
- Location: Hall C1
- IASLC CME Accredited
- Type: Plenary
- Track: N/A
- Moderators:Heather Wakelee, Eric Lim
-
+
Session Moderator
Presenter: Heather Wakelee- Abstract
Loading... -
+
Session Moderator
Presenter: Eric Lim- Abstract
Loading... -
+
PL03.01 - Session Introduction
Presenter: Heather Wakelee- Abstract
Loading... -
+
PL03.02 - Session Introduction
Presenter: Eric Lim- Abstract
Loading... -
+
PL03.03 - Personalised Smoking Cessation Support in a Lung Cancer Screening Programme: The Yorkshire Enhanced Stop Smoking Study (YESS)
Presenter: Rachael Louise Murray- Abstract
Loading... -
+
PL03.04 - Discussant
Presenter: Jacek Jassem- Abstract
Loading... -
+
PL03.05 - Live Q&A
- Abstract
Loading... -
+
PL03.06 - Lobar or Sub-lobar Resection for Peripheral Clinical Stage IA = 2 cm Non-small Cell Lung Cancer (NSCLC): Results From an International Randomized Phase III Trial (CALGB 140503 [Alliance])
Presenter: Nasser Khaled Altorki- Abstract
Loading... -
+
PL03.07 - Discussant
Presenter: Hisashi Saji- Abstract
Loading... -
+
PL03.08 - Live Q&A
- Abstract
Loading... -
+
PL03.09 - IMpower010:Overall Survival Interim Analysis of a Phase III Study of Atezolizumab vs Best Supportive Care in Resected NSCLC
Presenter: ENRIQUETA FELIP- Abstract
Loading... -
+
PL03.10 - Discussant
Presenter: Benjamin Besse- Abstract
Loading... -
+
PL03.11 - Live Q&A
- Abstract
Loading... -
+
PL03.12 - Progression Free Survival and Overall Survival in NADIM II Study
Presenter: Mariano Provencio- Abstract
Loading... -
+
PL03.13 - Discussant
Presenter: Masahiro Tsuboi- Abstract
Loading... -
+
PL03.14 - Discussant
Presenter: Corinne Faivre-Finn- Abstract
Loading... -
+
PL03.15 - Live Q&A
- Abstract
Loading...
